Diagnostic and Interventional Therapy in Acute Pancreatitis

August 8, 2011 updated by: University of Regensburg
The study aims to evaluate the course of patients with acute pancreatitis. Thereby we analyze different diagnostics and compare ultrasound, MRI and CT-scan in detection of necrotic areas and evaluate interventional therapy methods like percutaneous drainage techniques regarding the outcome. Laboratory values were assessed as well.

Study Overview

Status

Unknown

Conditions

Detailed Description

For laboratory values different inflammation markers were measured and compared.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Regensburg, Germany, 93053
        • Recruiting
        • Department of Internal medicine I, University of Regensburg
        • Contact:
        • Principal Investigator:
          • Tanja Bruennler, Dr. med.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

50 patients with acute pancreatitis

Description

Inclusion Criteria:

  • Age > 18 years
  • Acute pancreatitis
  • Written formal consent

Exclusion Criteria:

  • Pregnancy
  • Missing formal consent
  • Individual contraindications for CT-scan
  • MRI or endoscopic ultrasound

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Evaluation of one study cohort
Evaluation of different diagnostics and evaluation of outcome of patients who received percutaneous CT-guided drainage for necrotic debridement and analyze the further outcome

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Length of hospital stay
Time Frame: weekly
weekly

Secondary Outcome Measures

Outcome Measure
Time Frame
time to surgery
Time Frame: weekly
weekly
active necrosectomy
Time Frame: weekly
weekly
ICU stay
Time Frame: weekly
weekly

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jürgen Schölmerich, Prof., Director of Department of Internal Medicine I
  • Study Director: Stefan Feuerbach, Prof., Director of Department of Radiology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2008

Primary Completion (Anticipated)

December 1, 2012

Study Completion (Anticipated)

December 1, 2012

Study Registration Dates

First Submitted

June 13, 2008

First Submitted That Met QC Criteria

June 17, 2008

First Posted (Estimate)

June 18, 2008

Study Record Updates

Last Update Posted (Estimate)

August 9, 2011

Last Update Submitted That Met QC Criteria

August 8, 2011

Last Verified

June 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pancreatitis

Clinical Trials on CT-guided percutaneous drainage technique

3
Subscribe